Skip to main content
SpringerLink
Log in

Follicular Lymphoma

  • Living reference work entry
  • First Online:
Encyclopedia of Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 133 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References and Further Reading

  • Huet, S., Szafer-Glusman, E., Tesson, B., Xerri, L., Fairbrother, W. J., Mukhyala, K., Bolen, C., Punnoose, E., Tonon, L., Chassagne-Clément, C., Feugier, P., Viari, A., Jardin, F., Salles, G., & Sujobert, P. (2017a). BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab. American Journal of Hematology, 92, 515–519.

    Article  CAS  PubMed  Google Scholar 

  • Huet, S., Xerri, L., Tesson, B., Mareschal, S., Taix, S., Mescam-Mancini, L., Sohier, E., Carrère, M., Lazarovici, J., Casasnovas, O., Tonon, L., Boyault, S., Hayette, S., Haioun, C., Fabiani, B., Viari, A., Jardin, F., & Salles, G. (2017b). EZH2 alterations in follicular lymphoma: Biological and clinical correlations. Blood Cancer Journal, 7, e555.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jurinovic, V., Kridel, R., Staiger, A. M., Szczepanowski, M., Horn, H., Dreyling, M. H., Rosenwald, A., Ott, G., Klapper, W., Zelenetz, A. D., Barr, P. M., Friedberg, J. W., Ansell, S., Sehn, L. H., Connors, J. M., Gascoyne, R. D., Hiddemann, W.,Unterhalt, M., Weinstock, D. M., & Weigert, O. (2016). Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. Blood, 128, 1112–1120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kahl, B. S., & Yang, D. T. (2016). Follicular lymphoma: Evolving therapeutic strategies. Blood, 127, 2055–2063.

    Article  CAS  PubMed  Google Scholar 

  • Koch, K., Hoster, E., Ziepert, M., Unterhalt, M., Ott, G., Rosenwald, A., Hansmann, M. L., Bernd, W., Stein, H., Pöschel, V., Dreyling, M., Trümper, L., Löffler, M., Schmitz, N., Hiddemann, W., Pfreundschuh, M., & Klapper, W. (2016). Clinical, pathological and genetic features of follicular lymphoma grade 3A: A joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Annals of Oncology, 27, 1323–1329.

    Article  CAS  PubMed  Google Scholar 

  • Kridel, R., Chan, F. C., Mottok, A., Boyle, M., Farinha, P., Tan, K., Meissner, B., Bashashati, A., McPherson, A., Roth, A., Shumansky, K., Yap, D., Ben-Neriah, S., Rosner, J., Smith, M. A., Nielsen, C., Giné, E., Telenius, A., Ennishi, D., Mungall, A., Moore, R., Morin, R. D., Johnson, N. A., Sehn, L. H., Tousseyn, T., Dogan, A., Connors, J. M., Scott, D. W., Steidl, C., Marra, M. A., Gascoyne, R. D., & Shah, S. P. (2016). Histological transformation and progression in follicular lymphoma: A clonal evolution study. PLoS Medicine, 13, e1002197.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Laurent, C., Baron, M., Amara, N., Haioun, C., Dandoit, M., Maynadié, M., Parrens, M., Vergier, B., Copie-Bergman, C., Fabiani, B., Traverse-Glehen, A., Brousse, N., Copin, M. C., Tas, P., Petrella, T., Rousselet, M. C., Brière, J., Charlotte, F., Chassagne-Clement, C., Rousset, T., Xerri, L., Moreau, A., Martin, A., Damotte, D., Dartigues, P., Soubeyran, I., Peoch, M., Dechelotte, P., Michiels, J. F., de Mascarel, A., Berger, F., Bossard, C., Arbion, F., Quintin-Roué, I., Picquenot, J. M., Patey, M., Fabre, B., Sevestre, H., Le Naoures, C., Chenard-Neu, M. P., Bastien, C., Thiebault, S., Martin, L., Delage, M., Filleron, T., Salles, G., Molina, T. J., Delsol, G., Brousset, P., & Gaulard, P. (2017). Impact of expert pathologic review of lymphoma diagnosis: Study of patients from the French Lymphopath Network. Journal of Clinical Oncology, 35, 2008–2017.

    Article  PubMed  Google Scholar 

  • Le, K. S., Thibult, M. L., Just-Landi, S., Pastor, S., Gondois-Rey, F., Granjeaud, S., Broussais, F., Bouabdallah, R., Colisson, R., Caux, C., Ménétrier-Caux, C., Leroux, D., Xerri, L., & Olive, D. (2016). Follicular B lymphomas generate regulatory T cells via the ICOS/ICOSL pathway and are susceptible to treatment by anti-ICOS/ICOSL therapy. Cancer Research, 76, 4648–4660.

    Article  CAS  PubMed  Google Scholar 

  • Leich, E., Hoster, E., Wartenberg, M., Unterhalt, M., Siebert, R., Koch, K., Klapper, W., Engelhard, M., Puppe, B., Horn, H., Staiger, A. M., Stuhlmann-Laeisz, C., Bernd, H. W., Feller, A. C., Hummel, M., Lenze, D., Stein, H., Hartmann, S., Hansmann, M. L., Möller, P., Hiddemann, W., Dreyling, M., Ott, G., Rosenwald, A., & German Low Grade Lymphoma Study Group (GLSG). (2016). Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus. Leukemia, 30, 854–860.

    Article  CAS  PubMed  Google Scholar 

  • Louissaint, A., Jr., Schafernak, K. T., Geyer, J. T., Kovach, A. E., Ghandi, M., Gratzinger, D., Roth, C. G., Paxton, C. N., Kim, S., Namgyal, C., Morin, R., Morgan, E. A., Neuberg, D. S., South, S. T., Harris, M. H., Hasserjian, R. P., Hochberg, E. P., Garraway, L. A., Harris, N. L., & Weinstock, D. M. (2016). Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations. Blood, 128, 1093–1100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mackrides, N., Campuzano-Zuluaga, G., Maque-Acosta, Y., Moul, A., Hijazi, N., Ikpatt, F. O., Levy, R., Verdun, R. E., Kunkalla, K., Natkunam, Y., Lossos, I. S., Vega, F., & Chapman, J. (2017). Epstein-Barr virus-positive follicular lymphoma. Modern Pathology, 30, 519–529.

    Article  CAS  PubMed  Google Scholar 

  • Miao, Y., Hu, S., Lu, X., Li, S., Wang, W., Medeiros, L. J., & Lin, P. (2016). Double-hit follicular lymphoma with MYC and BCL2 translocations: A study of 7 cases with a review of literature. Human Pathology, 58, 72–77.

    Article  CAS  PubMed  Google Scholar 

  • Quintanilla-Martinez, L., Sander, B., Chan, J. K., Xerri, L., Ott, G., Campo, E., & Swerdlow, S. H. (2016). Indolent lymphomas in the pediatric population: Follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia. Virchows Archiv, 468, 141–157.

    Article  CAS  PubMed  Google Scholar 

  • Sarkozy, C., Trneny, M., Xerri, L., Wickham, N., Feugier, P., Leppa, S., Brice, P., Soubeyran, P., Gomes Da Silva, M., Mounier, C., Offner, F., Dupuis, J., Caballero, D., Canioni, D., Paula, M., Delarue, R., Zachee, P., Seymour, J., Salles, G., & Tilly, H. (2016). Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first-line Immunochemotherapy in the PRIMA trial. Journal of Clinical Oncology, 34, 2575–2582.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt, J., Ramis-Zaldivar, J. E., Nadeu, F., Gonzalez-Farre, B., Navarro, A., Egan, C., Montes-Mojarro, I. A., Marafioti, T., Cabeçadas, J., van der Walt, J., Dojcinov, S., Rosenwald, A., Ott, G., Bonzheim, I., Fend, F., Campo, E., Jaffe, E. S., Salaverria, I., & Quintanilla-Martinez, L. (2017). Mutations of MAP 2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood, 130, 323–327.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Siddiqi, I. N., Friedman, J., Barry-Holson, K. Q., Ma, C., Thodima, V., Kang, I., Padmanabhan, R., Dias, L. M., Kelly, K. R., Brynes, R. K., Kamalakaran, S., & Houldsworth, J. (2016). Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. Modern Pathology, 29, 570–581.

    Article  CAS  PubMed  Google Scholar 

  • Swerdlow, S., Campo, E., Harris, N. E., Jaffe, E. S., Pileri, S. A., Stein, H., Thiele, J., & Vardiman, J. W. (2016a). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press.

    Google Scholar 

  • Swerdlow, S. H., Kuzu, I., Dogan, A., Dirnhofer, S., Chan, J. K., Sander, B., Ott, G., Xerri, L., Quintanilla-Martinez, L., & Campo, E. (2016b). The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Archiv, 468, 259–275.

    Article  CAS  PubMed  Google Scholar 

  • Xerri, L., Dirnhofer, S., Quintanilla-Martinez, L., Sander, B., Chan, J. K., Campo, E., Swerdlow, S. H., & Ott, G. (2016). The heterogeneity of follicular lymphomas: From early development to transformation. Virchows Archiv, 468, 127–139.

    Article  CAS  PubMed  Google Scholar 

  • Xerri, L., Huet, S., Venstrom, J. M., Szafer-Glusman, E., Fabiani, B., Canioni, D., Chassagne-Clément, C., Dartigues-Cuilléres, P., Charlotte, F., Laurent, C., Gelas-Dore, B., Bolen, C. R., Punnoose, E., Bouabdallah, R., Brice, P., Morschhauser, F., Cartron, G., Olive, D., Salles, G., & a LYSA study. (2017). Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients. Human Pathology, 64, 128–136.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bio-Pathology, Institut Paoli-Calmettes, CRCM, INSERM, CNRS, Aix-Marseille Université, Marseille, France

    Luc Xerri

Authors
  1. Luc Xerri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luc Xerri .

Editor information

Editors and Affiliations

  1. NIJMEGEN, The Netherlands

    J.H.J.M. van Krieken

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Xerri, L. (2018). Follicular Lymphoma. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_3891-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_3891-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation